Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Arch Biochem Biophys ; 562: 1-8, 2014 Nov 15.
Article in English | MEDLINE | ID: mdl-25151305

ABSTRACT

Elevation in [Ca(2+)]i and activation of calpain-1 occur in central nervous system of SOD1(G93A) transgenic mice model of amyotrophic lateral sclerosis (ALS), but few data are available about the early stage of ALS. We here investigated the level of activation of the Ca(2+)-dependent protease calpain-1 in spinal cord of SOD1(G93A) mice to ascertain a possible role of the protease in the aetiology of ALS. Comparing the events occurring in the 120 day old mice, we found that [Ca(2+)]i and activation of calpain-1 were also increased in the spinal cord of 30 day old mice, as indicated by the digestion of some substrates of the protease such as nNOS, αII-spectrin, and the NR2B subunit of NMDA-R. However, the digestion pattern of these proteins suggests that calpain-1 may play different roles depending on the phase of ALS. In fact, in spinal cord of 30 day old mice, activation of calpain-1 produces high amounts of nNOS active species, while in 120 day old mice enhanced-prolonged activation of calpain-1 inactivates nNOS and down-regulates NR2B. Our data reveal a critical role of calpain-1 in the early phase and during progression of ALS, suggesting new therapeutic approaches to counteract its onset and fatal course.


Subject(s)
Amyotrophic Lateral Sclerosis/genetics , Calcium/metabolism , Calpain/metabolism , Nitric Oxide Synthase Type I/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Spinal Cord/metabolism , Amyotrophic Lateral Sclerosis/physiopathology , Animals , Disease Models, Animal , Disease Progression , Humans , Mice , Mice, Transgenic , Motor Neurons/metabolism , Nitric Oxide Synthase Type I/genetics , Proteolysis , Receptors, N-Methyl-D-Aspartate/genetics , Superoxide Dismutase/genetics , Superoxide Dismutase-1
2.
Cell Mol Life Sci ; 60(12): 2669-78, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14685690

ABSTRACT

The amount of calpastatin directly available in cytosol is under the control of [Ca2+] and [cyclic AMP]. Prolonged calpain activation also promotes degradation of calpastatin. The fluctuation of calpastatin concentration in cell soluble fraction is accompanied by an initial decrease in calpastatin gene expression, followed by a fivefold increase in its expression when the inhibitor protein is degraded. This process can be conceptualized as a mechanism to regulate calpastatin availability in the cell. This conclusion is supported by the fact that calpain, the other component of this proteolytic system, undergoes changes in its levels of expression in a much more limited manner. Furthermore, this process can be observed both in cells exposed to different natural stimuli, or in other cell lines. Modification of calpastatin gene expression might represent a new tool for the in vivo control of the regulatory machinery required for the modulation of Ca(2+)-dependent proteolysis.


Subject(s)
Calcium-Binding Proteins/metabolism , Calcium/metabolism , Calpain/metabolism , Peptide Hydrolases/metabolism , Calcium-Binding Proteins/genetics , Calpain/genetics , Cyclic AMP/metabolism , Humans
3.
J Biol Chem ; 276(42): 38426-32, 2001 Oct 19.
Article in English | MEDLINE | ID: mdl-11485997

ABSTRACT

Hypertensive rats from the Milan strain show a significant decrease in calpastatin activity as compared with normotensive control animals. Calpastatin deficiency is age-related and highly relevant in kidney, heart, and erythrocytes and of minor entity in brain tissue. In normotensives the changes during aging in the levels of calpastatin activity and mRNA are consistent with an increase of calpastatin protein. In hypertensive rats such a relationship during aging is not observed, because a progressive accumulation of mRNA is accompanied by a lower amount of calpastatin protein as compared with control rats. Together with the low level of calpastatin in kidney of hypertensive rats, a progressive accumulation of an active 15-kDa calpastatin fragment, previously shown to represent a typical product of calpain-mediated calpastatin degradation, is also observed. Evidence for such intracellular proteolysis by Ca(2+)-activated calpain is provided by the normalization of the calpastatin level, up to that of control animals, in hypertensive rats treated with drugs known to reduce both blood pressure and intracellular Ca(2+) influx. Further evidence is provided by the disappearance, in these conditions, of the 15-kDa calpastatin fragment. These data allow the conclusion that calpastatin degradation is a relevant part of the overall mechanism for regulating calpain activity.


Subject(s)
Aging , Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/metabolism , Hypertension/metabolism , Kidney/metabolism , Age Factors , Animals , Brain/metabolism , Chromatography, Ion Exchange , Down-Regulation , Electrophoresis, Polyacrylamide Gel , Erythrocytes/metabolism , Immunoblotting , Models, Biological , Myocardium/metabolism , RNA, Messenger/metabolism , Rats , Tissue Distribution
4.
Br J Cancer ; 84(7): 946-50, 2001 Apr 06.
Article in English | MEDLINE | ID: mdl-11286475

ABSTRACT

Cachexia is a syndrome characterized by profound tissue wasting that frequently complicates malignancies. In a cancer cachexia model we have shown that protein depletion in the skeletal muscle, which is a prominent feature of the syndrome, is mostly due to enhanced proteolysis. There is consensus on the views that the ubiquitin/proteasome pathway plays an important role in such metabolic response and that cytotoxic cytokines such as TNFalpha are involved in its triggering (Costelli and Baccino, 2000), yet the mechanisms by which the relevant extracellular signals are transduced into protein hypercatabolism are largely unknown. Moreover, little information is presently available as to the possible involvement in muscle protein waste of the Ca(2+)-dependent proteolysis, which may provide a rapidly activated system in response to the extracellular signals. In the present work we have evaluated the status of the Ca(2+)-dependent proteolytic system in the gastrocnemius muscle of AH-130 tumour-bearing rats by assaying the activity of calpain as well as the levels of calpastatin, the natural calpain inhibitor, and of the 130 kDa Ca(2+)-ATPase, both of which are known calpain substrates. After tumour transplantation, total calpastatin activity progressively declined, while total calpain activity remained unchanged, resulting in a progressively increasing unbalance in the calpain/calpastatin ratio. A decrease was also observed for the 130 kDa plasma membrane form of Ca(2+)-ATPase, while there was no change in the level of the 90 kDa sarcoplasmic Ca(2+)-ATPase, which is resistant to the action of calpain. Decreased levels of both calpastatin and 130 kDa Ca(2+)-ATPase have been also detected in the heart of the tumour-bearers. These observations strongly suggest that Ca(2+)-dependent proteolysis was activated in the skeletal muscle and heart of tumour-bearing animals and raise the possibility that such activation may play a role in sparking off the muscle protein hypercatabolic response that characterizes cancer cachexia.


Subject(s)
Cachexia/metabolism , Calcium-Binding Proteins/metabolism , Calcium-Transporting ATPases/metabolism , Calpain/metabolism , Muscle, Skeletal/metabolism , Myocardium/metabolism , Animals , Cachexia/etiology , Enzyme Activation , Liver Neoplasms, Experimental/complications , Liver Neoplasms, Experimental/metabolism , Male , Muscle, Skeletal/enzymology , Myocardium/enzymology , Rats , Rats, Wistar
5.
Biochem J ; 354(Pt 1): 25-30, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11171075

ABSTRACT

We have previously reported that, in neuroblastoma LAN-5 cells, calpastatin is in an aggregated state, close to the cell nucleus [de Tullio, Passalacqua, Averna, Salamino, Melloni and Pontremoli (1999) Biochem. J. 343, 467-472]. In the present paper, we demonstrate that aggregated calpastatin is predominantly in a phosphorylated state. An increase in intracellular free [Ca2+] induces both dephosphorylation of calpastatin, through the action of a phosphoprotein phosphatase, and its redistribution as a soluble inhibitor species. cAMP, but not PMA-induced phosphorylation, reverses calpastatin distribution favouring its aggregation. This intracellular reversible mechanism, regulating the level of cytosolic calpastatin, could be considered a strategy through which calpain can escape calpastatin inhibition, especially during earlier steps of its activation process.


Subject(s)
Calcium-Binding Proteins/metabolism , Chromatography, Ion Exchange , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Humans , Phosphorylation , Protein Kinase C/metabolism , Tumor Cells, Cultured
6.
Eur Respir J ; 18(5): 758-63, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11757624

ABSTRACT

Due to the lack of information on this topic, the Educational Group of the Italian Association of Hospital Pneumologists performed an open, multicentre, observational survey to evaluate home nebulizer practices in Italy. From May-December 1999, all patients attending one of the 27 participating chest clinics throughout Italy and who were or had been using a home nebulizer in the previous 6 months were consecutively enrolled. All patients completed a self-administered questionnaire on their current practices of home nebulization. Of the 1,721 questionnaires delivered, 1,257 were returned with an overall response rate of 73%. Most patients (82.8%) reported using their nebulizer for bronchopulmonary symptoms and the remaining patients only used theirs for upper respiratory tract diseases. Subjects using their nebulizer for lower respiratory symptoms were older (p<0.001), predominantly female (p<0.001) and used their nebulizer more frequently (p<0.001). Forty per cent of patients >60 yrs old used their nebulizer regularly, at least once a day. More than 60% of respondents never received any information from healthcare workers on the correct usage of their nebulizer, and >75% received no information on nebulizer hygiene and care. Patients who received information on the use and maintenance of their nebulizer from caregivers more commonly attended to these practices (p<0.01). The present survey suggests that home nebulizer use and maintenance in Italy are heterogeneous, and there is the need to implement better nebulizer practice.


Subject(s)
Nebulizers and Vaporizers/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Asthma/therapy , Child , Child, Preschool , Cross-Sectional Studies , Disinfection , Female , Humans , Italy , Logistic Models , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/therapy
7.
FEBS Lett ; 475(1): 17-21, 2000 Jun 09.
Article in English | MEDLINE | ID: mdl-10854849

ABSTRACT

In neuroblastoma LAN-5 cells during calpain activation, in addition to the two expressed 70 kDa and 30 kDa calpastatin forms, other inhibitory species are produced, having molecular masses of 50 kDa and 15 kDa. At longer times of incubation, both native and new calpastatin species disappear. The formation of these new calpastatins as well as the decrease in intracellular total calpastatin activity are mediated by calpain itself, as indicated by the effect of the synthetic calpain inhibitor I, which prevents both degradative processes. Analysis of the calcium concentrations required for the two processes indicates that the first conservative proteolytic event is mediated by micro-calpain, whereas the second one is preferentially carried out by m-calpain. The appearance of the 15 kDa form, containing only the calpastatin repetitive inhibitory domain and identified also in red cells of hypertensive rats as the major inhibitor form, can be considered a marker of intracellular calpain activation, and it can be used for the monitoring of the involvement of calpain in pathological situations.


Subject(s)
Calcium-Binding Proteins/metabolism , Calcium/metabolism , Calpain/metabolism , Neuroblastoma/metabolism , Animals , Humans , Rats , Tumor Cells, Cultured
8.
Biochem J ; 343 Pt 2: 467-72, 1999 Oct 15.
Article in English | MEDLINE | ID: mdl-10510315

ABSTRACT

Localization of the two main components of the Ca(2+)-dependent proteolytic system has been investigated in human neuroblastoma LAN-5 cells. Using a monoclonal antibody which recognizes the N-terminal calpastatin domain, it has been shown that this inhibitory protein is almost completely confined in two granule-like structures not surrounded by membranes. Similar calpastatin distribution has been found in other human and in murine cell types, indicating that aggregation of calpastatin is a general property and not an exclusive characteristic of neuronal-like cells. The existence of such calpastatin aggregates is confirmed by the kinetics of calpastatin-activity release during rat liver homogenization, which does not correspond to the rate of appearance of cytosolic proteins or to the disruption of membrane-surrounded organelles. Calpastatin distribution is affected by the intracellular increase in free Ca(2+), which results in calpastatin progressively becoming a soluble protein. However, calpain is distributed in the soluble cell fraction and, in activating conditions, partially accumulates on the plasma membrane. Similar behaviour has been observed in calpastatin localization in LAN-5 cells induced with retinoic acid, suggesting that the proteolytic system is activated during the differentiation process of these cells. The involvement of calpastatin in controlling calpain activity, rather than its activation process, and the utilization of changes in calpastatin localization as a marker of activation of the system is discussed.


Subject(s)
Calcium-Binding Proteins/metabolism , Calpain/metabolism , Neurons/enzymology , Neurons/metabolism , Animals , Calcimycin/pharmacology , Calcium/metabolism , Cell Differentiation/drug effects , Cell Membrane/drug effects , Cell Membrane/enzymology , Cell Membrane/metabolism , Cell Membrane Permeability , Cytosol/drug effects , Cytosol/enzymology , Cytosol/metabolism , Diffusion , Endopeptidases/metabolism , Enzyme Activation/drug effects , Humans , Liver/enzymology , Liver/metabolism , Mice , Neurons/cytology , Neurons/drug effects , Rats , Solubility , Tretinoin/pharmacology , Tumor Cells, Cultured
9.
JAMA ; 282(1): 54-61, 1999 Jul 07.
Article in English | MEDLINE | ID: mdl-10404912

ABSTRACT

CONTEXT: Studies have shown that an inflammatory response may be elicited by mechanical ventilation used for recruitment or derecruitment of collapsed lung units or to overdistend alveolar regions, and that a lung-protective strategy may reduce this response. OBJECTIVE: To test the hypothesis that mechanical ventilation induces a pulmonary and systemic cytokine response that can be minimized by limiting recruitment or derecruitment and overdistention. DESIGN AND SETTING: Randomized controlled trial in the intensive care units of 2 European hospitals from November 1995 to February 1998, with a 28-day follow-up. PATIENTS: Forty-four patients (mean [SD] age, 50 [18] years) with acute respiratory distress syndrome were enrolled, 7 of whom were withdrawn due to adverse events. INTERVENTIONS: After admission, volume-pressure curves were measured and bronchoalveolar lavage and blood samples were obtained. Patients were randomized to either the control group (n = 19): tidal volume to obtain normal values of arterial carbon dioxide tension (35-40 mm Hg) and positive end-expiratory pressure (PEEP) producing the greatest improvement in arterial oxygen saturation without worsening hemodynamics; or the lung-protective strategy group (n = 18): tidal volume and PEEP based on the volume-pressure curve. Measurements were repeated 24 to 30 and 36 to 40 hours after randomization. MAIN OUTCOME MEASURES: Pulmonary and systemic concentrations of inflammatory mediators approximately 36 hours after randomization. RESULTS: Physiological characteristics and cytokine concentrations were similar in both groups at randomization. There were significant differences (mean [SD]) between the control and lung-protective strategy groups in tidal volume (11.1 [1.3] vs 7.6 [1.1] mL/kg), end-inspiratory plateau pressures (31.0 [4.5] vs 24.6 [2.4] cm H2O), and PEEP (6.5 [1.7] vs 14.8 [2.7] cm H2O) (P<.001). Patients in the control group had an increase in bronchoalveolar lavage concentrations of interleukin (IL) 1beta, IL-6, and IL-1 receptor agonist and in both bronchoalveolar lavage and plasma concentrations of tumor necrosis factor (TNF) alpha, IL-6, and TNF-alpha, receptors over 36 hours (P<.05 for all). Patients in the lung-protective strategy group had a reduction in bronchoalveolar lavage concentrations of polymorphonuclear cells, TNF-alpha, IL-1beta, soluble TNF-alpha receptor 55, and IL-8, and in plasma and bronchoalveolar lavage concentrations of IL-6, soluble TNF-alpha receptor 75, and IL-1 receptor antagonist (P<.05). The concentration of the inflammatory mediators 36 hours after randomization was significantly lower in the lung-protective strategy group than in the control group (P<.05). CONCLUSIONS: Mechanical ventilation can induce a cytokine response that may be attenuated by a strategy to minimize overdistention and recruitment/derecruitment of the lung. Whether these physiological improvements are associated with improvements in clinical end points should be determined in future studies.


Subject(s)
Cytokines/metabolism , Inflammation Mediators/metabolism , Respiration, Artificial , Respiratory Distress Syndrome/immunology , Respiratory Distress Syndrome/therapy , Female , Humans , Male , Middle Aged , Positive-Pressure Respiration , Respiration, Artificial/adverse effects , Respiratory Function Tests
10.
FEBS Lett ; 450(1-2): 13-6, 1999 Apr 30.
Article in English | MEDLINE | ID: mdl-10350048

ABSTRACT

Calpastatin, the natural inhibitor of calpain, is present in rat brain in multiple forms, having different molecular masses, due to the presence of one (low Mr form) or four (high Mr form) repetitive inhibitory domains. Recombinant and native calpastatin forms are substrates of protein kinase C, which phosphorylates a single serine residue at their N-terminus. Furthermore, both low and high Mr calpastatins are phosphorylated by protein kinase C at the same site. These calpastatin forms are phosphorylated also by protein kinase A, although with a lower efficiency. The incorporation of a phosphate group determines an increase in the concentration of Ca2+ required to induce the formation of the calpain-calpastatin complex. This effect results in a large decrease of the inhibitory efficiency of calpastatins. We suggest that phosphorylation of calpastatin represents a mechanism capable to balance the actual amount of active calpastatin to the level of calpain to be activated.


Subject(s)
Calcium-Binding Proteins/metabolism , Protein Kinase C/metabolism , Animals , Brain/enzymology , Brain/metabolism , Calcium-Binding Proteins/isolation & purification , Calpain/antagonists & inhibitors , Cyclic AMP-Dependent Protein Kinases/metabolism , Enzyme Inhibitors/metabolism , Isoenzymes/metabolism , Phosphopeptides/analysis , Phosphorylation , Protein Kinase C/isolation & purification , Rats
11.
FEBS Lett ; 431(1): 55-8, 1998 Jul 10.
Article in English | MEDLINE | ID: mdl-9684864

ABSTRACT

Four recombinant calpastatin forms, deduced from rat brain mRNAs and differing in the number of inhibitory repetitive domains from zero to four, were expressed and characterized for their inhibitory efficiency on mu- and m-calpain. Although the most effective one is a truncated calpastatin form composed of the N-terminal region (domain L) and a single inhibitory domain, all inhibitors are more active against mu-calpain, but are preferentially degraded and inactivated by m-calpain. The protein form composed exclusively of a domain L is deprived of any inhibitory activity but prevents inhibition of calpain by the other calpastatin forms, indicating that this calpastatin region could be relevant in the recognition of the proteinase. A calpastatin form having molecular properties similar to those of the recombinant truncated calpastatin, has also been found in rat brain. It does not derive from proteolysis of a higher molecular mass precursor. The expression of multiple calpastatin forms may be relevant for the specific modulation of the different calpain isozymes normally present in a single cell type.


Subject(s)
Brain/physiology , Calcium-Binding Proteins/physiology , Animals , Calcium-Binding Proteins/genetics , Calcium-Binding Proteins/metabolism , Calpain/antagonists & inhibitors , Calpain/metabolism , Cloning, Molecular , Enzyme Inhibitors/metabolism , Escherichia coli , RNA, Messenger , Rats , Recombinant Fusion Proteins/metabolism
12.
FEBS Lett ; 422(1): 113-7, 1998 Jan 23.
Article in English | MEDLINE | ID: mdl-9475181

ABSTRACT

This work was undertaken to establish the forms of the calpain inhibitor, calpastatin, expressed in the brain tissue. Five cDNA clones were obtained and the corresponding amino acid sequences were deduced. Three of these proteins contain an N-terminal domain (domain L) and four inhibitory repeats typical of the calpastatin molecule. The other two are truncated forms, containing the domain L, free or associated with a single inhibitory repeat. Other differences, due to exon skipping, produce calpastatin forms with different susceptibility to posttranslational modifications. The more represented mRNA form corresponds to a calpastatin molecule containing the four inhibitory domains. These results may be useful to understand the involvement of calpain in the onset of acute and degenerative disorders of the central nervous system.


Subject(s)
Brain/metabolism , Calcium-Binding Proteins/chemistry , RNA, Messenger/genetics , Amino Acid Sequence , Animals , Central Nervous System Diseases/physiopathology , Cloning, Molecular , Liver/chemistry , Molecular Sequence Data , Protein Processing, Post-Translational/genetics , RNA, Messenger/metabolism , Rats , Sequence Alignment , Sequence Analysis, DNA , Serine Proteinase Inhibitors
13.
FEBS Lett ; 412(3): 433-8, 1997 Aug 04.
Article in English | MEDLINE | ID: mdl-9276442

ABSTRACT

Calpains, the thiol proteinases of the calcium-dependent proteolytic system, are regulated by a natural inhibitor, calpastatin, which is present in brain tissue in two forms. Although both calpastatins are highly active on human erythrocyte calpain, only one form shows a high inhibitory efficiency with both rat brain calpain isozymes. The second calpastatin form is almost completely inactive against homologous proteinases and can be converted into an active one by exposure to a phosphoprotein phosphatase, also isolated from rat brain. Phosphorylation of the active calpastatin by protein kinase C and protein kinase A promotes a decrease in its inhibitory efficiency. The interconversion between the two inhibitor forms seems involved in the adjustment of the level of intracellular calpastatin activity on specific cell requirements.


Subject(s)
Brain/metabolism , Calcium-Binding Proteins/metabolism , Calpain/antagonists & inhibitors , Protein Processing, Post-Translational , Animals , Brain/drug effects , Calcium-Binding Proteins/isolation & purification , Calcium-Binding Proteins/pharmacology , Calpain/pharmacology , Phosphoprotein Phosphatases/pharmacology , Phosphorylation , Rats
14.
Biochem J ; 308 ( Pt 1): 57-61, 1995 May 15.
Article in English | MEDLINE | ID: mdl-7755588

ABSTRACT

The degradation of troponin (Tn) subunits by calpain was studied by incubating either isolated cardiac Tns or myocardial cryosections with two different calpain isoenzymes isolated from rat skeletal muscle. Western-blot analysis with monoclonal antibodies against TnI and TnT showed that mu-calpain was at least ten times more active than m-calpain in degrading TnI and TnT both in vitro and in situ. TnC was completely resistant to both proteinase forms. Phosphorylation by cyclic AMP-dependent protein kinase (PKA) isolated from rat skeletal muscle reduced the sensitivity of TnI to degradation. This effect in combination with an increased efficiency of the endogenous inhibitor [Salamino, De Tullio, Michetti, Mengotti, Melloni and Pontremoli (1994) Biochem. Biophys. Res. Commun. 199, 1326-1332] probably reduces the proteolytic activity of calpain in cells on PKA stimulation. Conversely, phosphorylation by protein kinase C (PKC) resulted in a twofold increase in the degradation of TnI. Degradation by m-calpain was not modified by Tn phosphorylation. The different sensitivity to mu-calpain might be related to changes in TnI oligomeric structure. Indeed, on PKC phosphorylation, the apparent molecular mass of TnI calculated from the distribution coefficient of Tn complex in Sephadex G-100 matrix was reduced from 90 to 30 kDa suggesting dissociation of the Tn complex.


Subject(s)
Calpain/metabolism , Troponin/metabolism , Animals , Cyclic AMP-Dependent Protein Kinases/metabolism , In Vitro Techniques , Isoenzymes/metabolism , Molecular Weight , Muscles/enzymology , Myocardium/metabolism , Phosphoproteins/metabolism , Phosphorylation , Protein Kinase C/metabolism , Rats , Structure-Activity Relationship , Troponin I , Troponin T
15.
Biochim Biophys Acta ; 1194(2): 296-302, 1994 Sep 14.
Article in English | MEDLINE | ID: mdl-7522565

ABSTRACT

On the basis of selective recognition by antibodies directed against neutrophil membrane determinants, a new neutrophil protein (molecular mass 82 kDa) has been identified, and shown to be functionally correlated with the oxidative response evoked in these cells by agonist stimulation. The protein is present in neutrophil membrane fraction but only upon activation it becomes accessible to recognition by a specific monoclonal antibody. In these conditions a complete and selective inhibition of O2- production occurs. The presence of a new protein antigen in neutrophil membranes linked to the activation of the O2- producing multienzyme complex that becomes external to the cell surface in primed or activated cells, might be important for future approaches aiming at the control of neutrophil response and at the identification of the activated forms of these cells.


Subject(s)
Membrane Proteins/analysis , Neutrophils/metabolism , Respiratory Burst , Antibodies, Monoclonal , Epitopes/analysis , Epitopes/immunology , Humans , Membrane Proteins/immunology , Superoxides/metabolism
16.
Pediatr Res ; 36(2): 182-6, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7970932

ABSTRACT

When a 12-y-old girl suffering from isovaleric acidemia was treated with L-carnitine, there was a considerable increase in her blood and urine concentration of isovalerylcarnitine. When later the patient received an infusion of glycine in place of carnitine, isovalerylcarnitine reverted toward the low levels found in a normal subject. At the end of either treatment, erythrocyte calpain was measured and found to be decreased after carnitine therapy (140 versus 96 U/mg Hb with glycine or carnitine, respectively). Because we have previously shown that the activity of calpain isolated from erythrocytes was markedly modified by isovalerylcarnitine, the present results might be seen as the consequence of the chronic exposure of the patient's red blood cells to high levels of isovalerylcarnitine. The lowered calpain activity was also proved by an increase in erythrocyte band 3 phosphorylation together with an increased erythrocyte fragility after calcium loading in the presence of the ionophore A-23187. Calpastatin, the natural inhibitor of calpain, was only slightly modified.


Subject(s)
Calpain/blood , Carnitine/therapeutic use , Glycine/therapeutic use , Oxidoreductases Acting on CH-CH Group Donors , Pentanoic Acids/blood , Carnitine/analogs & derivatives , Carnitine/blood , Carnitine/urine , Child , Erythrocytes/drug effects , Erythrocytes/metabolism , Female , Hemiterpenes , Humans , Isovaleryl-CoA Dehydrogenase , Oxidoreductases/deficiency
17.
Biochem Biophys Res Commun ; 202(3): 1197-203, 1994 Aug 15.
Article in English | MEDLINE | ID: mdl-7520236

ABSTRACT

Reversible interconversion between calpastatin I and calpastatin II, the phosphorylated form of the inhibitor, has been induced in rat heart perfused with the combination Ca2+/A23187 ionophore or with cAMP. In the presence of the ionophore and increasing concentrations of Ca2+, calpastatin II is converted into calpastatin I; whereas the reverse reaction is induced by the addition of cAMP. Both interconversions leave substantially unmodified the amount of calpastatin I which inhibits mu-calpain with higher efficiency and accordingly keeps the proteinase in an permanent inactive state. On the contrary, expression of m-calpain activity is significantly repressed or alternatively largely augmented as a result of a profound increase or decrease in the level of calpastatin II induced by perfusion with cAMP or with Ca2+/ionophore respectively. Taken together our results demonstrate that bidirectional interconversion can take place in rat heart cells and through this mechanism the activity of m-calpain can be efficiently controlled. Ca2+ ions and cAMP are temptatively proposed as the natural stimuli responsible for the modulation of this overall process. Experimental evidences are provided indicating that the transition to the active form of mu-calpain involves association to the plasma membrane, a process competitively antagonized by calpastatin I; thus suggesting that interaction with one or the other ligand can affect the intracellular ratio between inactive and active mu-calpain forms.


Subject(s)
Calcium/pharmacology , Calpain/metabolism , Cyclic AMP/pharmacology , Myocardium/metabolism , Naphthalenes , Animals , Cell Membrane/metabolism , Heart/drug effects , In Vitro Techniques , Male , Phosphorylation , Polycyclic Compounds/metabolism , Rats
18.
Biochem Biophys Res Commun ; 199(3): 1326-32, 1994 Mar 30.
Article in English | MEDLINE | ID: mdl-8147876

ABSTRACT

Two calpastatins, with Mr 110 KD and named calpastatin I and II, have been isolated from rat heart and kidney and displayed distinct inhibitory efficiency with mu- and m-calpain, respectively, as those isolated from rat skeletal muscle. Whereas the level of calpastatin I always exceeds that of mu-calpain, the level of calpastatin II appears to be more closely correlated to the level of m-calpain. As previously shown for skeletal muscle, the two inhibitor proteins can be interconverted by a phosphorylation-dephosphorylation reaction; the enzyme responsible for phosphate incorporation in calpastatin I is now identified in c-AMP dependent protein kinase A. In rat erythrocytes, containing a single calpain form, the single low Mr calpastatin form does not undergo reversible phosphorylation and is equally efficient in respect to typical mu- and m-calpain. The presence of two interconvertible calpastatin forms provides the cells with a highly sensitive mechanism of regulation of the Ca(2+)-dependent proteolytic system.


Subject(s)
Calcium-Binding Proteins/metabolism , Calcium-Binding Proteins/pharmacology , Calpain/pharmacology , Cysteine Proteinase Inhibitors/metabolism , Erythrocytes/metabolism , Kidney/metabolism , Myocardium/metabolism , Protein Kinases/metabolism , Animals , Calcium-Binding Proteins/isolation & purification , Chromatography, Affinity , Chromatography, DEAE-Cellulose , Cyclic AMP-Dependent Protein Kinases/metabolism , Globins/metabolism , Humans , Kinetics , Phosphorylation , Protein Kinase C/metabolism , Protein Kinases/isolation & purification , Rats
19.
Biochem J ; 290 ( Pt 1): 191-7, 1993 Feb 15.
Article in English | MEDLINE | ID: mdl-8439288

ABSTRACT

Human erythrocytes contain a calpain activator protein with a molecular mass of approx. 40 kDa. The activator is present in association with the plasma membrane and promotes expression of calpain activity at a concentration of Ca2+ close to physiological values. The initial step of the activating mechanism involves association of the activator with calpain, followed by autoproteolytic activation of the proteinase in the presence of 1 microM Ca2+, at a rate identical to that induced by 1 mM Ca2+. In a reconstituted system, the activator binds to erythrocyte membranes, but not to phospholipid vesicles, suggesting the participation of an intrinsic membrane protein(s). In its membrane-associated form the activator selectively binds calpain, thus favouring interaction of the proteinase with the inner surface of plasma membranes. These results further confirm the importance of a natural activator protein in promoting intracellular activation of calpain under physiological conditions through a site-directed mechanism, which explains the high specificity of the proteinase for membrane of cytoskeletal proteins.


Subject(s)
Blood Proteins/pharmacology , Calpain/blood , Erythrocyte Membrane/metabolism , Erythrocytes/enzymology , Binding Sites , Calcium/pharmacology , Chromatography, Gel , Enzyme Activation , Humans , Iodoacetates/metabolism , Iodoacetic Acid
20.
Arch Biochem Biophys ; 298(1): 287-92, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1388013

ABSTRACT

The presence of low levels of calpastatin activity in erythrocytes of hypertensive rats affects regulation of calpain activity so it is highly susceptible to activation within physiological fluctuations in [Ca2+]. Under identical conditions, in red cells of normotensive rats, calpain activation is efficiently controlled by the high levels of calpastatin activity, and a progressive increase in proteinase activity can only be observed in parallel with a decrease in the level of calpastatin. In intact erythrocytes from hypertensive rats exposed to small variations in [Ca2+], degradation of anion transport protein (band 3) and Ca(2+)-ATPase appears as a primary event indicating that these two transmembrane proteins are probably early recognized as targets of intracellular calpain activity. Furthermore, band 3 protein seems to be structurally modified in erythrocytes from hypertensive rats, as indicated by its increased susceptibility to degradation in the presence of 10-50 microM Ca2+. In addition, when exposed to progressive and limited increases in [Ca2+], erythrocytes from hypertensive rats, but not those from normotensive rats, show a high degree of fragility that can be restored to normal values by inhibition of calpain. These results indicate that, within fluctuations in [Ca2+] close to physiological values, regulation of calpain activity is efficiently accomplished in normal erythrocytes but is completely lost in cells from hypertensive animals. Regulation is of critical importance in maintaining normal structural and functional properties of selective red cell membrane and cytoskeletal proteins, among which band 3 and Ca(2+)-ATPase appear to be the substrates with highest susceptibility to digestion by calpain.


Subject(s)
Calcium-Transporting ATPases/blood , Calpain/metabolism , Erythrocyte Membrane/metabolism , Hypertension/blood , Membrane Proteins/metabolism , Animals , Calcium/blood , Calcium-Binding Proteins/pharmacology , Enzyme Activation , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...